Alcatel-Lucent has announced two small cell contract wins with Uruguay’s Antel and Denmark’s TDC.
Administración Nacional de Telecomunicaciones, Uruguay’s leading mobile operator, has selected the vendor’s small cells tech to expand the reach of its network in high-traffic and hard-to-reach places such as homes, businesses, sports stadiums and shopping malls.
The contract is for a complete end-to-end small cells solution, comprising enterprise cells, home cells, Metrocells, Small Cells Gateway and a Management System.
The France-based vendor said initial deployment of the Gateway and Management System has been accomplished, while the installation of the small cells themselves began early this year.
A-L already supplies Antel with LTE and 3G technology for its mobile networks.
It said small cells will be particularly effective in Uruguay as 55 percent of the country’s population resides in the metropolitan area surrounding the nation’s capital, Montevideo.
Meanwhile, a more targeted approach has been agreed with TDC as the Danish operator looks to boost coverage and capacity.
TDC will deploy the small cells in two phases. This year it will expand coverage to its enterprise customers by offering a Femto VIP service. Next year, it plans to deploy small cells directly in the homes of customers requiring the enhanced service.
A-L promised greater scale of ultra-broadband access and services at a lower cost and with lower energy consumption.
Further, it claimed that the “unobtrusive design” of its small cells would be welcomed as Denmark is “one of the world’s most environmentally conscious nations”.
TDC’s Chief Technology Officer Kim Søgård Kristensen commented: “Providing small cells is a great solution for our enterprise customers. With the deployment of a small cell, an enterprise can have the voice reliability they need and their work efficiency will improved by eliminating dropped calls and enabling employees to simultaneously work with both mobile voice and data.”
According to A-L, its small cell portfolio now has over 65 commercial contracts, in more than 45 countries, with over 20 ongoing trials.